Niacin And Niacinamide Market
By Form;
Dry and LiquidBy Distribution Channel;
Hospital Pharmacies, Drug Stores, Hypermarkets & Supermarkets and OthersBy Geography;
North America, Europe, Asia Pacific, Middle East & Africa and Latin America - Report Timeline (2021 - 2031)Niacin and Niacinamide Market Overview
Niacin and Niacinamide Market (USD Million)
Niacin and Niacinamide Market was valued at USD 1,157.50 million in the year 2024. The size of this market is expected to increase to USD 1,717.59 million by the year 2031, while growing at a Compounded Annual Growth Rate (CAGR) of 5.8%.
Niacin And Niacinamide Market
*Market size in USD million
CAGR 5.8 %
| Study Period | 2025 - 2031 |
|---|---|
| Base Year | 2024 |
| CAGR (%) | 5.8 % |
| Market Size (2024) | USD 1,157.50 Million |
| Market Size (2031) | USD 1,717.59 Million |
| Market Concentration | Medium |
| Report Pages | 316 |
Major Players
- Lonza Group AG
- Koninklijke DSM N.V
- Bactolac Pharmaceutical Inc
- Merck KGaA
- BASF SE
- Foodchem International Corporation
- Evonik Industries AG
- Jubilant Life Sciences Limited
- Vertellus Specialties Inc
- Fagron NV
Market Concentration
Consolidated - Market dominated by 1 - 5 major players
Niacin And Niacinamide Market
Fragmented - Highly competitive market without dominant players
The Niacin and Niacinamide Market is expanding rapidly as supplement manufacturers and skincare brands introduce targeted formulations for metabolic and skin health. Around 65% of brand portfolios now include these ingredients to address wellness trends and efficacy expectations. Their role in promoting metabolic support and dermal rejuvenation continues to elevate market relevance and consumer adoption.
Wider Access Enabled by Strategic Partnerships
Close to 60% of brands have expanded product portfolios through mergers and partnerships with dermatology-focused companies and supplement distributors. These alliances streamline supply, marketing, and regulatory compliance. Through these strategic collaborations, companies are scaling distribution and integrating niacin-based solutions into broader wellness ecosystems.
Delivery Technology Elevating Performance Levels
Advancements in technological formulation — like microencapsulation and slow-release matrices — have improved ingredient stability and absorption by over 64%. These enhancements reduce side effects and elevate product efficiency. Smart delivery methods are enhancing consumer experience and setting new standards for niacin and niacinamide efficacy.
Strong Expansion Outlook Built on Innovation and Collaboration
With about 68% of health and skincare professionals endorsing niacinamide use, the segment’s future expansion appears secure. Investment in novel delivery platforms, clinically validated formulations, and co-branded product launches is shaping a promising growth trajectory. Continued innovation and partnerships will drive sustained adoption across nutrition, cosmeceutical, and therapeutic markets.
Niacin and Niacinamide Market Recent Developments
-
In February 2024, Evonik inaugurated a new production plant for sustainable cosmetic emollients at its Steinau site in Germany. This facility aims to meet the growing demand for eco-friendly beauty products and reduce the climate footprint of manufacturing processes.
-
In August 2024, Galderma announced a new scientific partnership with L’Oréal to advance dermatological research. This collaboration focuses on developing innovative technologies to address skin aging and other dermatological concerns.
Niacin And Niacinamide Market Segment Analysis
In this report, the Niacin and Niacinamide Market has been segmented by Form, Distribution Channel and Geography.
Niacin And Niacinamide Market, Segmentation by Form
The Form segmentation includes Dry and Liquid. The choice of form impacts the bioavailability, stability, and application versatility of niacin and niacinamide across pharmaceutical, nutraceutical, and cosmetic industries. Market growth is driven by increasing use in dietary supplements and fortified foods due to their essential role in metabolism regulation and cholesterol management.
Dry
Dry form dominates the market, primarily used in tablets, capsules, and powders due to ease of formulation and long shelf life. It offers high chemical stability and compatibility with other nutrients, making it ideal for large-scale supplement production. Manufacturers are focusing on micronized and coated powders to improve absorption efficiency and reduce gastrointestinal irritation.
Liquid
Liquid form is increasingly used in injectable formulations, topical applications, and fortified beverages. Its fast absorption rate makes it suitable for patients requiring rapid vitamin replenishment. Innovations in emulsion and encapsulation technologies are enhancing solubility and product stability, widening its scope in functional drinks and clinical nutrition.
Niacin And Niacinamide Market, Segmentation by Distribution Channel
The Distribution Channel segmentation includes Hospital Pharmacies, Drug Stores, Hypermarkets & Supermarkets and Others. Distribution networks are evolving with growing consumer access to OTC supplements and the expansion of e-commerce platforms. Strong marketing strategies and awareness campaigns about vitamin B3 deficiency are enhancing product accessibility worldwide.
Hospital Pharmacies
Hospital Pharmacies remain a key channel for prescription-grade niacin and niacinamide used in treating hyperlipidemia and pellagra. These facilities ensure strict dosage monitoring and patient compliance under medical supervision. Rising hospital-based treatment for cardiovascular and metabolic disorders sustains segment relevance.
Drug Stores
Drug Stores play a crucial role in over-the-counter sales of niacinamide supplements and skin formulations. The channel benefits from consumer trust and personalized pharmacist guidance. Strategic collaborations between nutraceutical brands and retail chains are enhancing brand visibility and distribution efficiency.
Hypermarkets & Supermarkets
Hypermarkets & Supermarkets are expanding their health and wellness aisles to meet growing consumer demand for self-care vitamins and preventive nutrition. Attractive product placement and bundled promotions drive impulse purchases. Retailers are increasingly adopting private-label supplement lines to capture a wider customer base.
Others
Others include online pharmacies, specialty nutrition stores, and direct-to-consumer channels. The shift toward digital retailing is revolutionizing product accessibility, supported by subscription models and personalized supplement recommendations. Increased consumer awareness of vitamin therapy and convenience-driven purchasing continues to accelerate this segment’s growth.
Niacin And Niacinamide Market, Segmentation by Geography
In this report, the Niacin and Niacinamide Market has been segmented by Geography into five regions: North America, Europe, Asia Pacific, Middle East and Africa and Latin America.
Regions and Countries Analyzed in this Report
North America
North America leads the market owing to strong consumer awareness of vitamin supplementation and a robust pharmaceutical infrastructure. The region benefits from widespread fortification programs and the presence of major nutraceutical manufacturers. Rising prevalence of cardiovascular diseases and proactive wellness initiatives drive sustained demand.
Europe
Europe demonstrates steady growth supported by government-backed nutritional guidelines and high demand for cosmeceutical formulations. The region’s stringent quality standards ensure product integrity across supplements and topical applications. The aging population and preference for preventive healthcare further support market expansion.
Asia Pacific
Asia Pacific experiences rapid expansion due to increasing disposable incomes, urbanization, and awareness of micronutrient deficiencies. Countries like China, India, and Japan are emerging as major consumers of fortified foods and OTC supplements. The growing nutraceutical industry and online retail adoption strengthen regional growth prospects.
Middle East & Africa
Middle East & Africa show rising adoption of niacin and niacinamide in healthcare and beauty products. Regional governments are promoting nutrition awareness and healthcare diversification initiatives. Expansion of retail pharmacy chains and improving distribution networks foster long-term market development.
Latin America
Latin America records consistent growth, driven by increasing healthcare spending and consumer preference for dietary supplements. Brazil and Mexico lead in fortified food production and pharmaceutical manufacturing. The integration of e-commerce platforms and public health campaigns on vitamin deficiency support broader market penetration.
Market Trends
This report provides an in depth analysis of various factors that impact the dynamics of Global Niacin and Niacinamide Market. These factors include; Market Drivers, Restraints and Opportunities Analysis.
Drivers, Restraints and Opportunity Analysis
Drivers :
- Increasing Focus on Health and Wellness
- Benefits of Niacin and Niacinamide
-
Rising Healthcare Expenditure - The global niacin and niacinamide market is witnessing an upward trajectory, propelled by factors such as rising healthcare expenditure across the globe. With increasing healthcare budgets allocated by governments and private institutions, there's a growing focus on preventive and therapeutic measures, including the incorporation of niacin and niacinamide in pharmaceuticals, dietary supplements, and cosmeceutical products.
As healthcare spending continues to rise, there's a corresponding increase in the demand for medications and nutritional supplements that address various health concerns. Niacin and niacinamide are valued for their diverse health benefits, ranging from cardiovascular health to skincare, making them essential components of many healthcare products.
The expanding healthcare infrastructure, coupled with advancements in medical research and technology, is driving the development of new formulations and applications for niacin and niacinamide. This trend is expected to further bolster market growth as manufacturers innovate to meet the evolving needs of healthcare professionals and consumers.
The rising healthcare expenditure globally is playing a pivotal role in driving the demand for niacin and niacinamide across multiple sectors, contributing to the overall growth and expansion of the market.
Restraints :
- Side Effects of Niacin
-
Availability of Substitutes - The availability of substitutes plays a crucial role in shaping the dynamics of the global niacin and niacinamide market. While niacin and niacinamide offer unique benefits and applications across different industries, there are alternative compounds and ingredients that serve similar purposes or provide comparable functionalities.
In the human nutrition segment, for example, other B vitamins or multivitamin supplements may offer alternatives to niacin and niacinamide for addressing specific dietary deficiencies. Similarly, in the pharmaceutical industry, certain medications may contain alternative compounds or formulations that serve similar therapeutic purposes as niacin and niacinamide.
In the cosmeceuticals sector, various skincare ingredients may offer similar benefits to niacinamide, such as antioxidants, peptides, and retinoids. These alternatives may be preferred by consumers based on factors such as formulation preferences, skin sensitivities, or specific skincare goals.
While substitutes exist for niacin and niacinamide, their availability and adoption are influenced by factors such as efficacy, safety profile, cost-effectiveness, and regulatory considerations. As such, market players must carefully assess the competitive landscape and consumer preferences to position niacin and niacinamide effectively against alternative ingredients and compounds. Additionally, ongoing research and development efforts may lead to the discovery of new applications or formulations that further differentiate niacin and niacinamide from potential substitutes, thereby sustaining their market relevance and demand.
Opportunities :
- Innovation in Product Development
- Rising Demand in Emerging Markets
-
Expanding Application Areas - The expansion of application areas in the global niacin and niacinamide market reflects the versatility and growing demand for these compounds across diverse industries. One notable trend is the increasing adoption of niacinamide in skincare products due to its proven efficacy in addressing various skin concerns. Skincare formulations incorporating niacinamide have gained popularity among consumers seeking solutions for acne, hyperpigmentation, and aging-related issues.
The pharmaceutical sector continues to explore new therapeutic applications for niacin and niacinamide, leveraging their beneficial properties in the treatment of various health conditions. From addressing vitamin deficiencies to managing cardiovascular diseases, these compounds offer promising opportunities for drug development and therapeutic innovation.
The expansion of application areas extends to the food and beverage industry, where niacin and niacinamide find utility as fortifying agents in fortified foods and dietary supplements. With the growing emphasis on nutrition and wellness, there is a rising demand for products enriched with essential vitamins like niacin and niacinamide, driving market growth in this segment.
The expanding application areas underscore the multifaceted nature of niacin and niacinamide, which continue to find new uses and opportunities across industries, contributing to the sustained growth of the global market.
Niacin And Niacinamide Market Competitive Landscape Analysis
Key players in Niacin and Niacinamide Market include;
- Brother Enterprises Holding Co., Ltd.
- Jubilant Ingrevia Limited (formerly Jubilant Life Sciences)
- Lonza Group AG
- Vertellus
- Zhejiang NHU Co., Ltd.
- Vanetta (Zhejiang Vanetta Industry Co., Ltd.)
- Lasons India Pvt. Ltd.
- BASF SE
- Evonik Industries AG
- Merck KGaA
- dsm-firmenich (formerly Koninklijke DSM N.V.)
- Hubei Guangji Pharmaceutical Co., Ltd.
- Shandong Hongda Biotechnology Co., Ltd.
- Zhejiang Lanbo Biotechnology Co., Ltd.
- Yuki Gosei Kogyo Co., Ltd.
In this report, the profile of each market player provides following information:
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- Introduction
- Research Objectives and Assumptions
- Research Methodology
- Abbreviations
- Market Definition & Study Scope
- Executive Summary
- Market Snapshot, By Form
- Market Snapshot, By Distribution Channel
- Market Snapshot, By Region
- Niacin and Niacinamide Market Dynamics
- Drivers, Restraints and Opportunities
- Drivers
- Increasing Focus on Health and Wellness
- Benefits of Niacin and Niacinamide
- Rising Healthcare Expenditure
- Restraints
- Side Effects of Niacin
- Availability of Substitutes
- Opportunities
- Innovation in Product Development
- Rising Demand in Emerging Markets
- Expanding Application Areas
- Drivers
- PEST Analysis
- Political Analysis
- Economic Analysis
- Social Analysis
- Technological Analysis
- Porter's Analysis
- Bargaining Power of Suppliers
- Bargaining Power of Buyers
- Threat of Substitutes
- Threat of New Entrants
-
Competitive Rivalry
- Drivers, Restraints and Opportunities
- Market Segmentation
- Niacin And Niacinamide Market, By Form, 2021 - 2031 (USD Million)
- Dry
- Liquid
- Niacin And Niacinamide Market, By Distribution Channel, 2021 - 2031 (USD Million)
- Hospital Pharmacies
- Drug Stores
- Hypermarkets & Supermarkets
- Others
- Niacin and Niacinamide Market, By Geography, 2021 - 2031 (USD Million)
- North America
- United States
- Canada
- Europe
- Germany
- United Kingdom
- France
- Italy
- Spain
- Nordic
- Benelux
- Rest of Europe
- Asia Pacific
- Japan
- China
- India
- Australia & New Zealand
- South Korea
- ASEAN (Association of South East Asian Countries)
- Rest of Asia Pacific
- Middle East & Africa
- GCC
- Israel
- South Africa
- Rest of Middle East & Africa
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- North America
- Niacin And Niacinamide Market, By Form, 2021 - 2031 (USD Million)
- Competitive Landscape
- Company Profiles
- Brother Enterprises Holding Co., Ltd.
- Jubilant Ingrevia Limited (formerly Jubilant Life Sciences)
- Lonza Group AG
- Vertellus
- Zhejiang NHU Co., Ltd.
- Vanetta (Zhejiang Vanetta Industry Co., Ltd.)
- Lasons India Pvt. Ltd.
- BASF SE
- Evonik Industries AG
- Merck KGaA
- dsm-firmenich (formerly Koninklijke DSM N.V.)
- Hubei Guangji Pharmaceutical Co., Ltd.
- Shandong Hongda Biotechnology Co., Ltd.
- Zhejiang Lanbo Biotechnology Co., Ltd.
- Yuki Gosei Kogyo Co., Ltd.
- Company Profiles
- Analyst Views
- Future Outlook of the Market

